Explorer les evidences

26,8 %The lipoarabinomannan antigen (LAM) test registered a sensitivity of 26.8% for tuberculosis diagnosis among people living with HIV in Nairobi, Kenya.

Kenyatuberculoseobservé 2022-2023publié 2024PloS onePubMeddocument de 7 observations

4,5 %Mortality was 4.5% amongst bacteriologically confirmed TB patients.

Kenyatuberculosepublié 2021Scientific reportsPubMeddocument de 12 observations

0,3 %Gatifloxacin resistance among HIV-negative tuberculosis patients in Western Kenya was 0.3%.

Kenyatuberculosepublié 2021BMC infectious diseasesPubMeddocument de 23 observations

90 %Among smear-positive pulmonary tuberculosis/HIV co-infected patients in Kenya between 2012 and 2015, 90% had a treatment outcome of cured.

Kenyatuberculose · VIH/sidaobservé 2012-2015publié 2020PloS onePubMeddocument de 6 observations

33,3 yearsThe mean age of the 9,026 smear-positive pulmonary tuberculosis/HIV co-infected patients aged 15–49 years in Kenya between 2012 and 2015 was 33.3 years.

Kenyatuberculose · VIH/sidaobservé 2012-2015publié 2020PloS onePubMeddocument de 6 observations

15,6 %The yield of active tuberculosis in internally-displaced persons camps was 15.6%.

Kenyatuberculosepublié 2022Tuberculosis research and treatmenteurope_pmcdocument de 8 observationsDOI 10.1155/2022/9947068

267,4 per_100000The median TB case notification rate among individuals aged ≥15 years in Kenya was 267.4 per 100,000 in 2015.

Kenyatuberculoseobservé 2015publié 2018BMC infectious diseaseseurope_pmcdocument de 12 observations

20 %Twenty percent of participants had confirmed tuberculosis.

Kenyatuberculosepublié 2022PloS onePubMeddocument de 10 observations

In 2010–14, HIV or tuberculosis was the top cause of death among adults aged 20–59 years.

Kenyatuberculose · VIH/sidaobservé 2010–14publié 2024The Lancet. Global healthPubMeddocument de 6 observations

32 %The proportion of HIV-infected TB patients declined from 32% in 2012 to 24% in 2020.

Kenyatuberculose · VIH/sidaobservé 2012–2020publié 2023BMC infectious diseasesPubMeddocument de 11 observations

3,5 %TB case fatality among HIV-negative people in Kenya rose from 3.5% in 2008 to 3.9% in 2018.

Kenyatuberculose · VIH/sidaobservé 2008publié 2022The international journal of tuberculosis and lung disease : the official journal of the IPubMeddocument de 8 observations

31,5 %Prevalence of Mtb-specific responses was similar regardless of HIV exposure (HIV exposed, 31.5%; HIV unexposed, 25.5%).

Kenyatuberculosepublié 2026The Journal of infectious diseasesPubMeddocument de 4 observations

Mtb-cfDNA signal decreased after tuberculosis treatment initiation, with near or complete Mtb-cfDNA clearance by 6 months after tuberculosis treatment initiation.

Kenyatuberculoseobservé 6 months after tuberculosis treatment initiationpublié 2022The Lancet. MicrobePubMeddocument de 6 observations

87,8 %542 (87.8%) of the 617 participants were negative for presumptive Mycobacterium tuberculosis.

Kenyatuberculoseobservé July 2021 to June 2022publié 2023Ethiopian journal of health sciencesPubMeddocument de 9 observations

95 %Uptake of antiretroviral therapy among TB/HIV co-infected patients was 95%.

Kenyatuberculose · VIH/sidaobservé 2012–2020publié 2023BMC infectious diseasesPubMeddocument de 11 observations

81,3 %Buccal swab specificity was 81.3% versus sputum Xpert and culture.

Kenyatuberculosepublié 2022PloS onePubMeddocument de 10 observations

3,4 %Rhizopus spp. were isolated from 3 out of 88 fungal-positive sputum samples (3.4%) among PTB patients in Kenya.

Kenyatuberculosepublié 2022BMC infectious diseasesPubMeddocument de 14 observations

81,6 %Out of the 201 eligible presumptive TB patients, 164 (81.6%) did not return at 2 weeks for follow up.

Kenyatuberculoseobservé February 2013 to February 2014publié 2019African Journal of Health SciencesOpenAlexdocument de 5 observations

42 %Among 10,328 eligible adolescents and young adults living with HIV in Kenyan HIV clinics, 4337 (42.0%) initiated tuberculosis preventive therapy.

Kenyatuberculosepublié 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 6 observations

11 339 patients11,339 (88%) of the included TB patients had pulmonary TB.

Kenyatuberculoseobservé 2012 to 2018publié 2021Scientific reportsPubMeddocument de 12 observations

9,9 %Mortality was 9.9% amongst clinically diagnosed TB patients.

Kenyatuberculosepublié 2021Scientific reportsPubMeddocument de 12 observations

45 %HIV-coinfection among TB cases in Kenya declined from 45% in 2008 to 27% in 2018.

Kenyatuberculose · VIH/sidaobservé 2008publié 2022The international journal of tuberculosis and lung disease : the official journal of the IPubMeddocument de 8 observations

15,2 %Tuberculosis was confirmed in 87 (15.2%) of 574 enrolled HIV-positive adult patients.

Kenyatuberculose · VIH/sidapublié 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument de 10 observations

58,2 %Out of 426 tuberculosis suspects, 58.2% had delayed in seeking medical care.

Kenyatuberculosepublié 2012DOAJ (DOAJ: Directory of Open Access Journals)OpenAlexdocument de 2 observations

0,9 %The prevalence of pulmonary tuberculosis was 0.9% among IPT-treated people living with HIV in western Kenya.

Kenyatuberculosepublié 2021BMC infectious diseasesPubMeddocument de 12 observations